CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 23 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,841 | -39.8% | 86,949 | 0.0% | 0.00% | – |
| Q2 2023 | $51,222 | +3.3% | 86,949 | 0.0% | 0.00% | – |
| Q1 2023 | $49,604 | -14.5% | 86,949 | 0.0% | 0.00% | – |
| Q4 2022 | $57,995 | -76.8% | 86,949 | -49.3% | 0.00% | – |
| Q3 2022 | $250,000 | -29.2% | 171,463 | -47.6% | 0.00% | – |
| Q2 2022 | $353,000 | -64.6% | 327,269 | 0.0% | 0.00% | – |
| Q1 2022 | $998,000 | -21.6% | 327,269 | 0.0% | 0.00% | – |
| Q4 2021 | $1,273,000 | -26.3% | 327,269 | -0.1% | 0.00% | – |
| Q3 2021 | $1,727,000 | -11.0% | 327,658 | 0.0% | 0.00% | – |
| Q2 2021 | $1,940,000 | -9.0% | 327,658 | +9.2% | 0.00% | – |
| Q1 2021 | $2,132,000 | +1662.0% | 299,969 | +1840.5% | 0.00% | – |
| Q4 2020 | $121,000 | – | 15,458 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 462,659 | $1,411,000 | 0.58% |
| Sio Capital Management, LLC | 422,598 | $1,289,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,550,000 | 0.22% |
| Affinity Asset Advisors, LLC | 400,000 | $1,220,000 | 0.20% |
| Atom Investors LP | 31,385 | $96,000 | 0.04% |
| Ikarian Capital, LLC | 104,741 | $319,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 514,780 | $1,570,000 | 0.01% |
| PURA VIDA INVESTMENTS, LLC | 77,568 | $237,000 | 0.01% |
| Point72 Asset Management, L.P. | 230,000 | $702,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 58,934 | $179,000 | 0.00% |